Search Results 1-10 of 16639 for Emicizumab

  1. Emicizumab-kxwh (subcutaneous route) - Mayo Clinic

    Description. Emicizumab-kxwh injection is used to prevent or decrease the frequency of bleeding episodes in patients with hemophilia A (congenital Factor VIII ...

  2. Emicizumab In Patients With Acquired Hemophilia A - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effectiveness of prophylactic emicizumab administered on a scheduled basis to prevent bleeds ...

  3. Hemophilia - Diagnosis and treatment - Mayo Clinic

    Emicizumab (Hemlibra). This is a newer drug that doesn't include clotting factors. This drug can help prevent bleeding episodes in people with hemophilia A ...

  4. Bispecific antibody therapy - Mayo Clinic

    Emicizumab (Hemlibra) binds factor IXa and factor X proteins to help prevent bleeding in people with hemophilia A. Faricimab (Vabysmo) blocks VEGF and Ang-2 ...

  5. Eculizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Eculizumab injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell ...

  6. Anti-inhibitor coagulant complex (intravenous route) - Side effects & uses - Mayo Clinic

    Emicizumab; Fitusiran; Tranexamic Acid. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of ...

  7. Idarucizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Idarucizumab injection is used in patients who are taking dabigatran (a blood thinner) during emergency or life-threatening situations when bleeding cannot be ...

  8. Ixekizumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Ixekizumab injection is used to treat moderate-to-severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

  9. Non Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  10. A Study To Evaluate The Safety And Effectiveness Of Using Eculizumab In Patients With Relapsing Neuromyelitis Optica - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of eculizumab treatment as compared to a placebo in patients with relapsing neuromyelitis ...